Synchronous Laryngeal Primary Cancer in a Patient with Esophageal Squamous Carcinoma Cell . A Case Report
Article Sidebar
Main Article Content
Abstract
Unexpected diagnosis of primary synchronous cancer in a patient with esophageal squamous carcinoma cell makes therapeutic management difficult. the careful evaluation of synchronous tumors is a primority aspect of management. we present the unusual case of an individual with esophageal squamous carcinomas cell synchronously associated with another primary laryngeal tumor. Initial clinical assessment was performed and consisting in a pan endoscopy and FDG-Pet scan / CT revealed the presence of synchronous head and neck and esophageal carcinoma (SHNEC). As recommended in the literature, surgical resection was not indicated. In this case radio chemotherapy often remains the only therapeutic alternative which guarantees a better result and improves the prognosis. The patient progressed well under concomitant radio chemotherapy even if complications inherent to this treatment required the cessation of treatment for a short period.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:963-8. [CrossRef]
Strong MS, Incze J, Vaughan CW. Field cancerization in the aerodigestive tract: its etiology, manifestation, and significance. J Otolaryngol 1984;13:1-6.
MAAMRI.A donnes épidémiologiques sur les cancers dans le monde et du maroc revue bibliographique, annales de sciences de la santé, N°1,20-29,2015.
Chen, Y.-H. et al. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy. Sci. Rep. 7, 41785; doi: 10.1038/srep41785 (2017). [CrossRef]
Morita M, Egashira A, Nakaji Y, Kagawa M, Sugiyama M, Yoshida D, et al. Treatment of squamous cell carcinoma of the esophagus synchronously asso-ciated with head and neck cancer. In Vivo (2017) 31:909–16. doi:10.21873/ invivo.11146
Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005; 46:752-7.
Li Q-W, Zhu Y-J, Zhang W-W, Yang H, Liang Y, Hu Y-H, et al. Chemoradiotherapy for synchronous multiple primary cancers with esopha-geal squamous cell carcinoma: a case-control study. J Cancer (2017) 8:563–9. doi:10.7150/jca.17408 [CrossRef]
Lee JS, Ahn JY, Choi KD, Song HJ, Kim YH, Lee GH, et al. Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome. Korean J Intern Med (2016) 31:253–9. doi:10.3904/kjim.2014.182 [CrossRef]
Shinoto M,Shioyama Y, sasaki T, Nakamura K, ohura H, Higaki Y, YamaguchiT. Clinical resultats of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer ; Am J Clin Oncol.2011;362-366. [CrossRef]
Chen Y, Chang JY, Jeter M, Guerrero T, et al. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: single-institution experience. J Thorac Oncol (2006) 1:252–9. Doi:10.1016/ S1556-0864(15)31576-8. [CrossRef]
NIWA Y.KOIKE M. salvage pharyngolaryngectomy .dis esophagus.2016 29 ;598-602. [CrossRef]
ORDU AD,NIEDER C. Association between radiation dose and pathological complete response after preoperative radiochemotherapy in esophageal squamous cell cancer. anticancer Res.2014;34:7255-7261.